Tacrolimus use in lupus nephritis: A systematic review and meta-analysis

This publication has 44 references indexed in Scilit:

• Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
  Annals of the Rheumatic Diseases, 2012
• Systematic review of the epidemiology of systemic lupus erythematosus in the Asia‐Pacific region: Prevalence, incidence, clinical features, and mortality
  Arthritis Care & Research, 2011
• Short-term Outcomes of Induction Therapy With Tacrolimus Versus Cyclophosphamide for Active Lupus Nephritis: A Multicenter Randomized Clinical Trial
  American Journal of Kidney Diseases, 2011
• The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide
  Annals of the Rheumatic Diseases, 2010
• Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
  Journal of the American Society of Nephrology, 2009
• How did cyclophosphamide become the drug of choice for lupus nephritis?
  Nephrology Dialysis Transplantation, 2008
• Successful Treatment of Class V+IV Lupus Nephritis with Multitarget Therapy
  Journal of the American Society of Nephrology, 2008
• Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
  Controlled Clinical Trials, 1996
• Evidence for the Superiority of Immunosuppressive Drugs and Prednisone over Prednisone Alone in Lupus Nephritis
  New England Journal of Medicine, 1984
• Treatment of Diffuse Proliferative Lupus Nephritis with Prednisone and Combined Prednisone and Cyclophosphamide
  New England Journal of Medicine, 1978